Skip to content
DataLookout
Menu

NCT06521892

Interventions on Non-prescription Dispensing of Antibiotics in Community Pharmacies

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 6 words Show 5 more changesShow less
    • Trial status changed: Unknown → Completed
    • Start date moved earlier from Aug 25, 2024 to Jul 11, 2024
    • Interventions modified
    • Enrollment target: estimated 400 to confirmed 436
    • Primary and study completion dates changed from estimate of Aug 25, 2025 to Sep 18, 2025
  2. Minor Changed Registry marked status Unknown; last known: Enrolling by Invitation
  3. Minor Primary and study completion dates: Jul 25, 2025 to Aug 25, 2025
    • Start date changed from estimate of Jul 25, 2024 to Aug 25, 2024
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Proportion of antibiotics dispensing without a prescription
Timeframe: baseline, First month after intervention, 3, 6, and 12 months after intervention

Arms and interventions

intervention groupExperimental

Participants in intervention group will receive a packaged-intervention.The intervention was implemented over a four-week period in the intervention group, with measures including centralized offline training(Week 1), continuous online reinforcement learning(Weeks 2-4), facilitation of public supervision channels(Weeks 1-4), and government department coordination(Weeks 1-4).

control groupNo intervention

Participants in control group would receive routine drug supervision and management measures, such as inspections conducted under existing annual or risk-based regulatory arrangements, review of prescription dispensing and pharmacy quality-management records, investigation of public complaints, and corrective or enforcement action when violations were identified. But the control group of pharmacies would not receive any of the study-specific intervention components during the trial.

Behavioral: A multicomponent intervention combining pharmacy staff education, continuous online reinforcement, facilitation of public supervision, and coordination with local drug regulatory authorities

Sites

1 site in 1 country

  • Hubei Provincial Drug AdministrationWuhan, Hubei, China